Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival

SpringerPlus

Table 5 Significant (2-tailed) correlations between various parameters in women with LLABCs undergoing NAC

	PSYCHOLOGICAL PARAMETERS^a	STATISTICAL SIGNIFICANCE*
		r_xy	p-value
TNM TUMOUR (T) CLASSIFICATION	HADS (ANXIETY)	0.296	0.001
TNM TUMOUR (T) CLASSIFICATION	HADS (DEPRESSION)	0.291	0.002
	MRS (HAPPINESS)	-0.185	0.049
	MRS (CLEAR HEADEDNESS)	-0.249	0.008
	MRS (RELAXATION)	-0.236	0.011
CLINICAL RESPONSE IN BREAST TO NAC	HADS (DEPRESSION)	0.218	0.020
	MRS (HAPPINESS)	-0.217	0.021
	MRS (CLEAR HEADEDNESS)	-0.217	0.021
PATHOLOGICAL RESPONSE IN BREAST TO NAC	MRS (CLEAR HEADEDNESS)	0.263	0.010
PATHOLOGICAL RESPONSE IN BREAST TO NAC	MRS (CONFIDENCE)	0.266	0.009